Image courtesy of Ellume The chairman of the Senate health committee has dubbed a new low-cost, at-home, diagnostic a genuine breakthrough in COVID-19 testing.
FDA has authorized the Ellume COVID-19 home test for non-prescription use in adults and children 2 years and up, whether they are symptomatic or not. The first-of-its-kind test has been heralded as a genuine breakthrough in COVID-19 testing and comes at a pivotal time in America s ongoing battle against the pandemic as the country is expected to have two authorized vaccines by the end of the week.
Ellume, a digital diagnostics company headquartered in Queensland, Australia with U.S. operations in Valencia, CA, says the test will help reduce the spread of COVID-19 through rapid self-detection, providing users with real-time results at home, enabling self-isolation and patient education on escalation of medical care. Alongside the recently authorized COVID-19 vaccine, Ellume’s self-test will pro
FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test omaha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omaha.com Daily Mail and Mail on Sunday newspapers.